BG64213B1 - Глюкокортикоидселективни противовъзпалителни средства - Google Patents

Глюкокортикоидселективни противовъзпалителни средства Download PDF

Info

Publication number
BG64213B1
BG64213B1 BG104698A BG10469800A BG64213B1 BG 64213 B1 BG64213 B1 BG 64213B1 BG 104698 A BG104698 A BG 104698A BG 10469800 A BG10469800 A BG 10469800A BG 64213 B1 BG64213 B1 BG 64213B1
Authority
BG
Bulgaria
Prior art keywords
carbon atoms
twelve carbon
twelve
alkyl
aryl
Prior art date
Application number
BG104698A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG104698A (en
Inventor
Michael J. Coughlan
Michael E. Kort
James P. Edwards
Todd K. Jones
Original Assignee
Abbott Laboratories
Ligand Pharmaceuticals,Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories, Ligand Pharmaceuticals,Inc filed Critical Abbott Laboratories
Publication of BG104698A publication Critical patent/BG104698A/xx
Publication of BG64213B1 publication Critical patent/BG64213B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG104698A 1998-02-13 2000-08-17 Глюкокортикоидселективни противовъзпалителни средства BG64213B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/023,913 US6380207B2 (en) 1998-02-13 1998-02-13 Glucocortiocoid-selective antiinflammatory agents
PCT/US1999/003210 WO1999041257A1 (en) 1998-02-13 1999-02-15 Glucocorticoid-selective antiinflammatory agents

Publications (2)

Publication Number Publication Date
BG104698A BG104698A (en) 2001-05-31
BG64213B1 true BG64213B1 (bg) 2004-05-31

Family

ID=21817891

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104698A BG64213B1 (bg) 1998-02-13 2000-08-17 Глюкокортикоидселективни противовъзпалителни средства

Country Status (24)

Country Link
US (1) US6380207B2 (no)
EP (1) EP1053240B1 (no)
JP (1) JP2002503666A (no)
KR (1) KR20010040940A (no)
CN (1) CN1153771C (no)
AT (1) ATE237620T1 (no)
AU (1) AU760511B2 (no)
BG (1) BG64213B1 (no)
BR (1) BR9907847A (no)
CA (1) CA2320911A1 (no)
DE (1) DE69906938T2 (no)
DK (1) DK1053240T3 (no)
ES (1) ES2197618T3 (no)
HK (1) HK1033309A1 (no)
HU (1) HUP0100846A3 (no)
IL (1) IL137509A0 (no)
NO (1) NO20004052L (no)
NZ (1) NZ506012A (no)
PL (1) PL342999A1 (no)
PT (1) PT1053240E (no)
SK (1) SK284076B6 (no)
TR (1) TR200002345T2 (no)
WO (1) WO1999041257A1 (no)
ZA (1) ZA99533B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
DE60113032T2 (de) 2000-10-30 2006-07-06 Pfizer Products Inc., Groton Glukokortikoidrezeptor-Modulatoren
US7026484B2 (en) * 2001-02-23 2006-04-11 Ligand Pharmaceuticals Incorporated Tricyclic androgen receptor modulator compounds and methods
EP1467730A4 (en) 2002-01-22 2010-03-10 Univ California Non-steroid ligands for the glucocorticoid receptor, compositions and uses thereof
KR100492913B1 (ko) * 2002-08-23 2005-06-03 주식회사 태평양 피부 감작 및 자극을 완화하는 피부 외용제 조성물
CA2496867A1 (en) 2002-08-28 2004-03-11 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment methods
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
DE20301728U1 (de) * 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
EP1558618A1 (en) * 2002-10-11 2005-08-03 Ligand Pharmaceuticals, Inc. 5-(1 ,1 -CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO- 5H /-CHROMENO[3,4-f ] QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
TW200410968A (en) * 2002-10-11 2004-07-01 Ligand Pharm Inc 5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
US7235662B2 (en) * 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
EP1656142A4 (en) * 2003-08-22 2011-06-22 Ligand Pharm Inc 6-CYCLOAMINO-2-QUINOLINONE DERIVATIVES AS MODULATORS ANDROGEN RECEPTOR COMPOUNDS
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
AU2004292445B2 (en) 2003-11-21 2010-02-04 Zalicus Inc. Methods and reagents for the treatment of inflammatory disorders
WO2005090282A1 (en) 2004-03-12 2005-09-29 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
CA2598216C (en) * 2005-06-17 2014-04-08 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
EP1916896A4 (en) 2005-08-26 2010-08-11 Univ California NOT STEROID-antiandrogens
EP1956906A4 (en) 2005-11-09 2009-12-30 Combinatorx Inc METHODS, COMPOSITIONS AND KITS FOR THE TREATMENT OF PATHOLOGIES
BRPI0619519A2 (pt) * 2005-12-09 2011-10-04 Hoffmann La Roche compostos de propionamida como agentes antiinflamatórios
CN101326169B (zh) * 2005-12-09 2011-11-16 霍夫曼-拉罗奇有限公司 作为抗炎剂的糖皮质激素受体调节剂
US8269612B2 (en) 2008-07-10 2012-09-18 Black & Decker Inc. Communication protocol for remotely controlled laser devices
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US9908182B2 (en) 2012-01-30 2018-03-06 Black & Decker Inc. Remote programming of a power tool
US8919456B2 (en) 2012-06-08 2014-12-30 Black & Decker Inc. Fastener setting algorithm for drill driver
US10011006B2 (en) 2013-08-08 2018-07-03 Black & Decker Inc. Fastener setting algorithm for drill driver

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT800519E (pt) 1994-12-22 2004-03-31 Ligand Pharm Inc Compostos moduladores de receptores de esteroides e metodos
US5696130A (en) 1994-12-22 1997-12-09 Ligand Pharmaceuticals Incorporated Tricyclic steroid receptor modulator compounds and methods
US5693133A (en) 1995-05-10 1997-12-02 Akzo Nobel Nv Asbestos free roof coatings

Also Published As

Publication number Publication date
SK11962000A3 (sk) 2001-03-12
US20010049377A1 (en) 2001-12-06
CA2320911A1 (en) 1999-08-19
ZA99533B (en) 1999-07-26
CN1153771C (zh) 2004-06-16
NZ506012A (en) 2003-03-28
BR9907847A (pt) 2001-01-09
ATE237620T1 (de) 2003-05-15
SK284076B6 (sk) 2004-09-08
NO20004052L (no) 2000-10-12
KR20010040940A (ko) 2001-05-15
DE69906938D1 (de) 2003-05-22
DK1053240T3 (da) 2003-08-11
JP2002503666A (ja) 2002-02-05
PT1053240E (pt) 2003-09-30
US6380207B2 (en) 2002-04-30
BG104698A (en) 2001-05-31
AU760511B2 (en) 2003-05-15
CN1297451A (zh) 2001-05-30
ES2197618T3 (es) 2004-01-01
HK1033309A1 (en) 2001-08-24
WO1999041257A1 (en) 1999-08-19
PL342999A1 (en) 2001-07-16
AU2600399A (en) 1999-08-30
HUP0100846A2 (hu) 2001-09-28
IL137509A0 (en) 2001-07-24
EP1053240B1 (en) 2003-04-16
TR200002345T2 (tr) 2000-11-21
HUP0100846A3 (en) 2003-03-28
EP1053240A1 (en) 2000-11-22
DE69906938T2 (de) 2004-02-26
NO20004052D0 (no) 2000-08-11

Similar Documents

Publication Publication Date Title
BG64213B1 (bg) Глюкокортикоидселективни противовъзпалителни средства
EP1208095B1 (en) Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes
CA3029857C (en) Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof
KR910000897B1 (ko) 레베카마이신 동족체
BG64317B1 (bg) Глюкокортикоид-селективни противовъзпалителни средства
US6436986B1 (en) Glucocorticoid receptor antagonists for treatment of diabetes
TW200808808A (en) Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
KR960015002B1 (ko) 광학 활성 8-메톡시 퀴놀론카복실산 유도체, 이의 제조방법 및 이의 중간체
US6268375B1 (en) 10, 11-difluoromethylenedioxycamptothecin compounds with topoisomerase I inhibition
Endo et al. Synthesis of 7-substituted indolactam-V: An introduction of hydrophobic moieties on the indole ring
CA1330663C (en) Thiazolidinedione derivatives
US4348392A (en) 8α-Substituted ergoline-I derivatives
CN111848572B (zh) 酰胺类化合物及其制备方法和用途
WO2022134262A1 (zh) 二吡咯甲烯-1-酮类化合物及其制备方法
US4895853A (en) Antitumor alkaloids
SAIGA et al. Synthesis of 1, 2, 3, 4-tetrahydro-β-carboline derivatives as hepatoprotective agents. IV. Positional isomers of 1, 2, 3, 4-tetrahydro-2-methylthiothiocarbonyl-β-carboline-3-carboxylic acid and its 1-alkylated derivatives
CZ20002894A3 (cs) Protizánětlivé prostředky selektivní na glukokortikoidy
MXPA00007902A (en) Glucocorticoid-selective antiinflammatory agents
EP1912963A2 (en) Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease
KR790000947B1 (ko) 헤테로싸이클릭 화합물의 제조방법
US4123545A (en) N-Propyl-3(β-hydroxyethyl)-3-(meta-hydroxyphenyl)-pyrrolidine
CS257791B2 (en) Method of eburnamenine's racemic and optically active derivatives' transstereoisomers production
DK151630B (da) Analogifremgangsmaade til fremstilling af n-phthalidyl-5-fluoruracilderivater
WO2024081961A2 (en) Ester analogs of psilocin, processes for the preparation thereof, and methods of use
CN117586251A (zh) 杂芳基并哌啶类衍生物及其药物组合物和应用